Carol Thomas Daily

A new Redfin survey reveals overwhelming bipartisan support for housing affordability policies, creating a powerful public mandate for a landmark bill now stalled.

Incyte's Opzelura cream is one step closer to EU approval for atopic dermatitis, signaling a new era for patients and a major win for the company.

As semiconductor and EV battery demand soars, Flash by Redspher enters South Korea, betting its unique entrepreneur-led model can outmaneuver giants.

As diamond mines close, Ottawa prepares a major announcement in Yellowknife, likely deploying a multi-billion dollar toolkit to turn the NWT into a critical minerals hub.

As SpaceX's stock endures post-IPO turbulence, brokers like FP Markets are offering CFDs to trade the volatility. But what are the real risks and rewards?

A new hospital in Dingxi gets power, but the real story is a national strategy to fuse high-tech infrastructure with traditional medicine for regional growth.

The specialty distributor's latest capital raise is more than financial housekeeping. It's a calculated move to extend debt and fuel a proven M&A engine.

Billions in rework and wasted labor plague the construction industry. A new analysis reveals a simple fix with a massive ROI that most projects still ignore.

As dental offices struggle with staffing, Cloud Dentistry's digital marketplace just won a major innovation award for its modern, flexible solution.

As CEO David Cordani transitions to Executive Chair, The Cigna Group Foundation unveils a new grant that's more than a farewell gift—it's a strategic move.

Canada's top medical body is backing a sweeping new law to protect kids online, shifting the debate from parental controls to platform accountability.

Matt Marino's recent CEO award is more than a local honor. It signals a strategic shift in telecom, where rapid growth is fueled by community investment.

NAVER's venture arm invests in SAZO, a startup whose AI agents automate the messy world of cross-border commerce, from customs to payments.

Trigon Pacific's proposal for a new LPG export facility is now open for public comment, highlighting a complex web of opportunity, competition, and conflict.

The Zero Proof's acquisition of The New Bar signals a new era for the nearly $5B non-alcoholic sector, merging national e-commerce with cultural presence.

New research reveals AI is finding software flaws 16 times faster than we can fix them, leaving a 95% 'invisibility gap' for corporate security teams.

Days after SpaceX's historic IPO, brokers are offering instant access via CFDs. Is this the democratization of finance or a high-stakes gamble for retail investors?

Early trial data for Verastem Oncology's VS-7375 reveals significant anti-tumor activity and a good safety profile, igniting hope for tough-to-treat cancers.

The Canadian government is preparing a landmark 'Building Canada Act,' signaling a coordinated strategy for infrastructure, energy, and Indigenous relations.

A Michigan ENT group's partnership with an MSO reveals a larger trend of consolidation reshaping specialty medicine, balancing physician autonomy with corporate scale.